537 related articles for article (PubMed ID: 30745811)
1. Imbalance of erythropoiesis and iron metabolism in patients with thalassemia.
Huang Y; Lei Y; Liu R; Liu J; Yang G; Xiang Z; Liang Y; Lai Y
Int J Med Sci; 2019; 16(2):302-310. PubMed ID: 30745811
[No Abstract] [Full Text] [Related]
2. Erythropoiesis and Iron Homeostasis in Non-Transfusion-Dependent Thalassemia Patients with Extramedullary Hematopoiesis.
Huang Y; Liu R; Wei X; Liu J; Pan L; Yang G; Lai Y
Biomed Res Int; 2019; 2019():4504302. PubMed ID: 30834265
[TBL] [Abstract][Full Text] [Related]
3. Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions.
Porter JB; Cappellini MD; Kattamis A; Viprakasit V; Musallam KM; Zhu Z; Taher AT
Br J Haematol; 2017 Jan; 176(2):288-299. PubMed ID: 27917462
[TBL] [Abstract][Full Text] [Related]
4. Iron Status in Newly Diagnosed
Susanah S; Rakhmilla LE; Ghozali M; Trisaputra JO; Moestopo O; Sribudiani Y; Idjradinata PS; Maskoen AM
Biomed Res Int; 2021; 2021():5560319. PubMed ID: 33954177
[TBL] [Abstract][Full Text] [Related]
5. [Status of iron metabolism and erythropoietic proliferation in children with various genotypes of thalassemia].
Mai HR; Li CG; Wang Y; Shi HS; Zhao WL; Chen YS; Chen XW
Zhongguo Dang Dai Er Ke Za Zhi; 2010 Aug; 12(8):602-4. PubMed ID: 20704788
[TBL] [Abstract][Full Text] [Related]
6. Growth differentiation factor 15 is related to anemia and iron metabolism in heart allograft recipients and patients with chronic heart failure.
Przybyłowski P; Wasilewski G; Bachorzewska-Gajewska H; Golabek K; Dobrzycki S; Małyszko J
Transplant Proc; 2014 Oct; 46(8):2852-5. PubMed ID: 25380934
[TBL] [Abstract][Full Text] [Related]
7. Erythropoiesis-driven regulation of hepcidin in human red cell disorders is better reflected through concentrations of soluble transferrin receptor rather than growth differentiation factor 15.
Fertrin KY; Lanaro C; Franco-Penteado CF; de Albuquerque DM; de Mello MR; Pallis FR; Bezerra MA; Hatzlhofer BL; Olbina G; Saad ST; da Silva Araújo A; Westerman M; Costa FF
Am J Hematol; 2014 Apr; 89(4):385-90. PubMed ID: 24860871
[TBL] [Abstract][Full Text] [Related]
8. Hepcidin and diabetes are independently related with soluble transferrin receptor levels in chronic dialysis patients.
Belo L; Rocha S; Valente MJ; Coimbra S; Catarino C; Bronze-da-Rocha E; Rocha-Pereira P; do Sameiro-Faria M; Oliveira JG; Madureira J; Fernandes JC; Miranda V; Santos-Silva A
Ren Fail; 2019 Nov; 41(1):662-672. PubMed ID: 31296086
[No Abstract] [Full Text] [Related]
9. Markers of ineffective erythropoiesis in non-transfusion dependent β-thalassaemia.
Khairullah S; Jackson N
Med J Malaysia; 2021 Jan; 76(1):41-45. PubMed ID: 33510107
[TBL] [Abstract][Full Text] [Related]
10. Erythropoiesis and Iron Parameters in Transfusion-dependent and Nontransfusion-dependent Thalassemias.
Ozturk Z; Gumuslu S; Yalcin K; Kupesiz A
J Pediatr Hematol Oncol; 2021 Jul; 43(5):186-192. PubMed ID: 34157011
[TBL] [Abstract][Full Text] [Related]
11. Liver iron concentrations and urinary hepcidin in beta-thalassemia.
Origa R; Galanello R; Ganz T; Giagu N; Maccioni L; Faa G; Nemeth E
Haematologica; 2007 May; 92(5):583-8. PubMed ID: 17488680
[TBL] [Abstract][Full Text] [Related]
12. Serum iron metabolism and erythropoiesis in patients with myelodysplastic syndrome not receiving RBC transfusions.
Cui R; Gale RP; Zhu G; Xu Z; Qin T; Zhang Y; Huang G; Li B; Fang L; Zhang H; Pan L; Hu N; Qu S; Xiao Z
Leuk Res; 2014 May; 38(5):545-50. PubMed ID: 24598841
[TBL] [Abstract][Full Text] [Related]
13. The association between growth differentiation factor-15, erythroferrone, and iron status in thalassemic patients.
Youssry I; Samy RM; AbdelMohsen M; Salama NM
Pediatr Res; 2024 Mar; 95(4):1095-1100. PubMed ID: 37464096
[TBL] [Abstract][Full Text] [Related]
14. Correlation of hepcidin and serum ferritin levels in thalassemia patients at Chiang Mai University Hospital.
Tantiworawit A; Khemakapasiddhi S; Rattanathammethee T; Hantrakool S; Chai-Adisaksopha C; Rattarittamrong E; Norasetthada L; Charoenkwan P; Srichairatanakool S; Fanhchaksai K
Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33565577
[TBL] [Abstract][Full Text] [Related]
15. Altered erythropoiesis and iron metabolism in carriers of thalassemia.
Guimarães JS; Cominal JG; Silva-Pinto AC; Olbina G; Ginzburg YZ; Nandi V; Westerman M; Rivella S; de Souza AM
Eur J Haematol; 2015 Jun; 94(6):511-8. PubMed ID: 25307880
[TBL] [Abstract][Full Text] [Related]
16. Serum Hepcidin as a Diagnostic Marker of Severe Iron Overload in Beta-thalassemia Major.
Kaddah AM; Abdel-Salam A; Farhan MS; Ragab R
Indian J Pediatr; 2017 Oct; 84(10):745-750. PubMed ID: 28600663
[TBL] [Abstract][Full Text] [Related]
17. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin.
Tanno T; Bhanu NV; Oneal PA; Goh SH; Staker P; Lee YT; Moroney JW; Reed CH; Luban NL; Wang RH; Eling TE; Childs R; Ganz T; Leitman SF; Fucharoen S; Miller JL
Nat Med; 2007 Sep; 13(9):1096-101. PubMed ID: 17721544
[TBL] [Abstract][Full Text] [Related]
18. Characterization of iron metabolism and erythropoiesis in erythrocyte membrane defects and thalassemia traits.
Sulovska L; Holub D; Zidova Z; Divoka M; Hajduch M; Mihal V; Vrbkova J; Horvathova M; Pospisilova D
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Jun; 160(2):231-7. PubMed ID: 26592557
[TBL] [Abstract][Full Text] [Related]
19. Soluble transferrin receptor levels and soluble transferrin receptor/log ferritin index in the evaluation of erythropoietic status in childhood infections and malignancy.
Dimitriou H; Stiakaki E; Markaki EA; Bolonaki I; Giannakopoulou C; Kalmanti M
Acta Paediatr; 2000 Oct; 89(10):1169-73. PubMed ID: 11083370
[TBL] [Abstract][Full Text] [Related]
20. [Oxidative Stress Status and Its Effect on Regulation of Hepcidin in Patients with HbHCS].
Wang L; Huang LC; Li YY; Feng QR; Liao GP; Chen JH; Zhou YL; Zhou TH; Yin XL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Oct; 26(5):1465-1470. PubMed ID: 30295269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
